CDw17 (Lactosylceramide or LacCer) (clone HO18.3G-6.F5 ), anti-human

CDw17 (Lactosylceramide or LacCer) (clone HO18.3G-6.F5 ), anti-human

€0.00
In stock
SKU
AC-AH12962
Catalog Number: AC-AH12962
Size: 20 µg, 100 µg
Isotype: Mouse
Clone Name: HO18.3G-6.F5
Applications: IF, FC
Datasheet

Request Information
Background:
CD17 is an intermediate glycosphingolipid from the metabolism of higher gangliosides that localizes to sphingolipid-sterol rafts. CD17 is detectable in monocytes, granulocytes, basophils, platelets, a subset of peripheral B cells (CD19+) and tonsil dendritic cells. It is rapidly down regulated on activated granulocytes and is upregulated on IL-2 activated T lymphocytes. CD17 binds to bacteria and may function in phagocytosis. VEGF-treated endothelial cells can produce CD17, which can then mediate signaling toward PECAM-1 expression and angiogenesis. Tumor necrosis factor Ī � (TNFĪ �)-induced astrogliosis (astrocyte proliferation and glial fibrillary acidic protein (GFAP) upregulation) in response to neuro-inflammation (i.e. spinal cord injury) causes an increase in intracellular levels of CD17. Aberrant levels of glycosphingolipids are a feature of cancer cells and may influence integrin clustering and internalization.
Primary Accession:
Other Accession:
More Information
Is Featured? No
Write Your Own Review
You're reviewing:CDw17 (Lactosylceramide or LacCer) (clone HO18.3G-6.F5 ), anti-human